5-HT7 receptor antagonists
US7910588B2 · kind B2 · utility
1Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2008 |
| Grant date | Mar 22, 2011 |
| Priority date | — |
| Expiry date | Sep 30, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine:where A is —C(H)═ or —N═ and R1-7 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.